Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Ecolab's (ECL) Nalco Water Opens Customer Experience Center

Published 09/11/2019, 11:09 PM
Updated 07/09/2023, 06:31 AM
ISRG
-
BAX
-
ECL
-
MASI
-

Ecolab Inc.’s (NYSE:ECL) Nalco Water recently opened a customer experience center at its production plant. Notably, the company aims to demonstrate how the company’s technologies can reduce water use and optimize costs. This is expected to boost Ecolab’s Global Industrial segment.

Per management, a full range of Nalco’s cutting-edge water technologies is utilized at the plant that produces water treatment chemistries. The system uses reverse osmosis, ultrafiltration membranes and Nalco Water’s 3D TRASAR to treat waste water from different locations. This causes an overall reduction of freshwater use by 20%.

For investors’ notice, 3D TRASAR Technology for Cooling Water was launched by Nalco in 2015 to address complex water management needs of the industry. The system delivers the appropriate chemistry response to ensure a balanced, efficient and safe cooling system.

Ecolab’s Water Treatment Offerings at a Glance

Ecolab is a leading provider of water, hygiene and energy technologies and services. The company’s Global Industrial segment consists of Water, Food & Beverage, Paper and Textile Care operating units and is one of the major revenue drivers. The segment contributed 36.7% of total revenues in the last reported quarter.

Notably, Ecolab offers treatment services for raw water, cooling water and waste water through real-time data monitoring and water management software tools.

In June, Nalco unveiled a new offering, LegionGuard LG25, which is designed to lower the waterborne pathogen Legionella pneumophila in drinking water systems. (Read More: Ecolab's Nalco Water to Boost Public Health With New Offering)

Freshwater Crisis Goes Global

The world is currently struggling with dwindling water resources, threatening a staggering number of lives.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Libya, Yemen and Jordan are already facing severe water scarcity and the United States might also face the same. Notably, states like Texas, Oklahoma, Arizona, Kansas, New Mexico and Nevada are apprehended to be running out of water.

Per management, demand for freshwater is expected to outpace supply by 40% by 2030.

Reflective of these, the global water treatment systems market size is anticipated to be valued at $44.01 billion by 2025 at a CAGR of 7.1% (per Grand View Research).

Hence, Ecolab’s latest developments have been well-timed.

Price Performance

In a year’s time, shares of this Zacks Rank #3 (Hold) company have rallied 26% against the industry’s 4.4% decline.

Key Picks

A few better-ranked stocks in the broader medical sector are Baxter International (NYSE:BAX) , Intuitive Surgical (NASDAQ:ISRG) and Masimo Corporation (NASDAQ:MASI) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Baxter’s long-term earnings are expected to grow 12.8%.

Intuitive Surgical’s long-term earnings are projected to increase 12.8%.

Masimo’s long-term earnings are estimated to rise 20.5%.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

See these 7 breakthrough stocks now>>



Ecolab Inc. (ECL): Free Stock Analysis Report

Masimo Corporation (MASI): Free Stock Analysis Report

Intuitive Surgical, Inc. (ISRG): Free Stock Analysis Report

Baxter International Inc. (BAX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.